If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSymphony Env. Regulatory News (SYM)

Share Price Information for Symphony Env. (SYM)

Share Price is delayed by 15 minutes
Get Live Data
8.25    0.00 (0.00%)
Bid:
7.50
Ask:
9.00
Spread: 1.50 (20.00%)
Market Cap: £19.50m
SYM Live PriceLast checked at - London Stock Exchange

Intraday Symphony Env. Share Chart

Trading Update and EU Case

18 Jan 2024 07:00

RNS Number : 0570A
Symphony Environmental Tech. PLC
18 January 2024
 

18 January 2024

 

Symphony Environmental Technologies plc

("Symphony" or the "Company")

 

(1) Trading update

(2) EU Case - date of judgment

 

Symphony Environmental Technologies plc (AIM: SYM), global specialists in technologies that make plastic and rubber products smarter, safer and more sustainable, announces the following updates.

 

Trading update

 

Revenue for the year ended 31 December 2023 was marginally higher than prior year at £6.35 million (2022: £6.15 million) with revenue for the second half of the year at £2.78m (2023 H1: £3.56 million). Gross margins and distribution costs are expected to be in line with H1 2023.

We advised in our 2023 interim statement that "some key trials were extended into H2-2023" and this continues to be an ongoing theme which is delaying the crystallisation of certain pipeline revenues. Also as previously advised, we continue into 2024 waiting for regulatory approvals for both d2w and d2p products in some important markets, over which we have no control on timescale.

In line with previous statements, opportunities for Symphony remain significant, and whilst these are taking considerably longer to convert than originally anticipated, a combination of more positive conversations, trials and other factors give the Board confidence that these can and will be converted in the short to medium term.

 

EU Case

 

After two years of written proceedings, the case brought by Symphony against the Commission, Parliament, and Council of the European Union was heard on 20 March 2023 in the General Court of the EU in Luxembourg. Symphony's case is that Art. 5 of the Single-use plastics Directive 2019/904 if and to the extent that it relates to oxo-biodegradable plastics, is unlawful and the Company is claiming substantial financial compensation.

We can now advise that Judgment will be delivered in open court at 9.30am (CET) on 31 January 2024.

Symphony has legal advice from Leading Counsel that Article 5 applies to oxo-degradable plastics, but not to oxo-biodegradable plastics such as those made with Symphony's d2w technology, but the global confusion caused by the wording of the legislation has been obstructing and delaying the adoption of the technology. For every day it remains in force Symphony suffers loss, but more important, ordinary plastic continues to be used, with thousands of tons getting into the open environment every week, where it will persist for 50 years or more. There is an urgent need for the adoption of d2w technology, which is already compulsory in the Middle East, so that it will quickly biodegrade leaving no microplastics or harmful residues.

 

Enquiries

Symphony Environmental Technologies Plc

+44 (0) 20 8207 5900

Michael Laurier, CEO

Ian Bristow, CFO

www.symphonyenvironmental.com

 

Zeus (Nominated Adviser and Joint Broker)

+44 (0) 203 829 5000

David Foreman / Kieran Russell (Investment Banking)

Dominic King (Corporate Broking) 

NOTES TO EDITORS:

About Symphony Environmental Technologies plc

www.symphonyenvironmental.com

 

Symphony has developed a range of additives, concentrates and master-batches marketed under its d2p® ("designed to protect") trademark, which can be incorporated in a wide variety of plastic and non-plastic products so as to provide protection against many different types of bacteria, viruses, fungi, algae, moulds, and insects, and against fire. d2p products also include odour, moisture and ethylene adsorbers as well as other types of food-preserving technologies. For an overview see www.d2p.net Symphony has launched d2p anti-microbial household gloves and toothbrushes and "Symfresh" food-packaging and is developing a range of other d2p finished-products for retail sale.

Symphony has also developed a biodegradable plastic technology which addresses the problem of persistent microplastics, by turning ordinary plastic at the end of its service-life into a waxy substance which is biodegradable. It is then no longer a plastic and can be bioassimilated in the open environment in a similar way to a leaf without leaving microplastics behind. The technology is branded d2w® and appears as a droplet logo on many thousands of tonnes of plastic packaging and other plastic products around the world, much of which has been recycled. In some countries, most recently Yemen, oxo-biodegradable plastic is mandatory for short-life plastic products.

d2w technology was studied for three years in the Oxomar project, sponsored by the French government, which concluded that plastic made with Symphony's d2w oxo-biodegradable technology will biodegrade in seawater significantly more efficiently than conventional plastic. See https://www.biodeg.org/subjects-of-interest/agriculture-and-horticulture/the-marine-environment/ 

Following this report, the scientists allowed bacteria commonly found in the open environment access to d2w oxo-biodegradable plastic containing Carbon 13. They found Carbon 13 in the carbon dioxide exhaled by the bacteria, proving beyond doubt that the plastic had been bioassimilated by the bacteria.

Symphony has complemented its d2w and d2p product ranges with d2c "compostable resins and products" that have been tested to US and EU composting standards and has invested in Eranova - a French company extracting starch for making plastics out of algae.

Symphony has also developed the d2Detector®, a portable device which analyses plastics and detects counterfeit products. This is useful for government officials tasked with enforcing legislation, and Symphony's d2t tagging and tracer technology is available for further security.

Symphony has a diverse and growing customer-base and has established itself as an international business with over 70 distributors around the world. Products made with Symphony's plastic technologies are now available in nearly 100 countries and in many different product applications. Symphony itself is accredited to ISO9001 and ISO14001.

Symphony is a founder-member of The BPA (www.biodeg.org) and actively participates in the Committee work of the British Standards Institute (BSI), the American Standards Organisation (ASTM), the European Standards Organisation (CEN), and the International Standards Organisation (ISO).

Further information on the Group can be found at www.symphonyenvironmental.com and twitter @SymphonyEnv See also Symphony on Instagram. A Symphony App is available for downloading to smartphones.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLGDBXUBDGSR
Date   Source Headline
13th Jan 20127:00 amRNSTrading Update
22nd Sep 20117:00 amRNSDirectors Dealings
20th Sep 20117:00 amRNSInterim Results
12th Sep 20117:00 amRNSTRADING & PRODUCT CLARIFICATION
6th Sep 201112:56 pmRNSInterim Results Date
17th Aug 201111:31 amRNSHolding(s) in Company
9th Aug 201112:09 pmRNSHolding(s) in Company
24th Jun 201111:29 amRNSResult of Annual General Meeting
24th Jun 201110:00 amRNSAGM Statement
23rd Jun 20117:00 amRNSd2w Update
22nd Jun 201111:48 amRNSNotification of Major Interest in Shares
1st Jun 20117:00 amRNSNotice of AGM
20th May 20117:00 amRNSExercise of Options and Issue of Equity
16th May 20117:00 amRNSIssue of Equity and Directors Dealings
27th Apr 20114:28 pmRNSHolding(s) in Company
21st Apr 20117:00 amRNSUS Distribution Agreement commences
11th Apr 20117:00 amRNSExercise of Options
5th Apr 20117:00 amRNSFinal Results
31st Mar 20117:00 amRNSChange of Adviser
28th Feb 20117:00 amRNSTotal Voting Rights
23rd Feb 20117:00 amRNSUSA Distribution Agreement and major PR campaign
9th Feb 20113:45 pmRNSExercise of Options and Issue of Equity
31st Jan 20113:30 pmRNSExercise of Options and Issue of Equity
14th Jan 20111:45 pmRNSHolding(s) in Company
11th Jan 20113:00 pmRNSHolding(s) in Company
1st Dec 20101:15 pmRNSHolding(s) in Company
29th Oct 20108:50 amRNSTotal Voting Rights
12th Oct 20102:00 pmRNSExercise of warrants
9th Sep 201012:45 pmRNSDirector/PDMR Shareholding
8th Sep 20103:30 pmRNSGrant of share options
6th Sep 20107:00 amRNSHalf Yearly Report
3rd Sep 201012:45 pmRNSExercise of warrants
6th Aug 201012:20 pmRNSInterim Results date and new technology contract
30th Jun 20103:50 pmRNSCompletion of reorganisation
21st Jun 201010:50 amRNSDirector/PDMR Shareholding
14th Jun 20107:00 amRNSDirector's dealings
28th May 20102:40 pmRNSTotal Voting Rights
28th May 201010:40 amRNSResult of AGM
17th May 201012:00 pmRNSDirectorate Change
11th May 20105:20 pmRNSIssue of Equity
5th May 20107:00 amRNSLeading Hotel Group to Use d2w Technology
29th Apr 20107:00 amRNSNotice of AGM
1st Apr 201012:26 pmRNSShare Options
30th Mar 201010:30 amRNSDirector/PDMR Shareholding
30th Mar 20107:00 amRNSFinal Results
26th Mar 201012:50 pmRNSChange of Registered Office
8th Mar 20108:00 amRNSNotice of Results
25th Jan 201011:30 amRNSShare Options
7th Jan 20107:00 amRNSBNY Mellon Level 1 ADR Programme
16th Dec 20097:00 amRNSDistribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.